Page last updated: 2024-11-05

dimethylcarbamyl chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dimethylcarbamyl chloride: searcher request; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6598
CHEMBL ID1527556
CHEBI ID82280
SCHEMBL ID924
MeSH IDM0041102

Synonyms (98)

Synonym
carbamyl chloride,n-dimethyl-
tl 389
n,n-dimethylcarbamyl chloride
dimethylcarbamic acid chloride
wln: gvn1&1
n,n-dimethylcarbamoyl chloride
n,n-dimethylcarbamidoyl chloride
chloroformic acid dimethylamide
carbamoyl chloride, dimethyl-
(dimethylamino)carbonyl chloride
dimethylcarbamoyl chloride
nsc122671
dimethylcarbamidoyl chloride
nsc-122671
dimethylcarbamyl chloride
carbamic chloride, dimethyl-
79-44-7
dimethylcarbamic chloride
carbamic acid,n,n-dimethyl,chloride
inchi=1/c3h6clno/c1-5(2)3(4)6/h1-2h
NCGC00091795-01
dimethyl carbamoyl chloride
hsdb 2656
dimethylamid kyseliny chlormravenci [czech]
chlorid kyseliny dimethylkarbaminove [czech]
rcra waste number u097
nsc 122671
rcra waste no. u097
un2262
einecs 201-208-6
dimethylkarbamoylchlorid [czech]
dimethyl carbamyl chloride
brn 0878197
n,n-dimethylcarbamic acid chloride
dimethylcarbamoylchloride
ccris 257
dimethylchloroformamide
carbamyl chloride, n,n-dimethyl-
dimethylcarbamyl chloride, 98%
D0695
AKOS000120154
NCGC00091795-02
NCGC00091795-03
C19175
NCGC00254074-01
tox21_300116
tox21_201334
NCGC00258886-01
dtxcid30512
cas-79-44-7
dtxsid1020512 ,
dimethylaminoformyl chloride
carbamic chloride, n,n-dimethyl-
chlorid kyseliny dimethylkarbaminove
unii-5d54s95gt6
dimethylcarbamoyl chloride [un2262] [corrosive]
dimethylamid kyseliny chlormravenci
dimethylkarbamoylchlorid
ec 201-208-6
5d54s95gt6 ,
FT-0629527
STL370332
dimethylcarbamoyl chloride [hsdb]
dimethylcarbamoyl chloride [iarc]
BBL027301
SCHEMBL924
CHEBI:82280 ,
chloroformic acid dimethyl amide
n,n-dimethyl-carbamoyl chloride
dimethylcarbarnyl chloride
dimethyl carbamylchloride
dimethylcarbamoylchlorid
me2ncocl
dimethyl carbamic acid chloride
n,n-dimethylcarbamic chloride
n,n-dimethyl-carbamoylchloride
dimethylcarbamylchloride
dimethyl carbamoylchloride
(ch3)2ncocl
n,n-dimethyl-carbamic chloride
n,n-dimethyl carbamyl chloride
dimethyl-carbamoyl chloride
n,n-dimethyl-carbamic acid chloride
clc(o)n(ch3)2
dimethylaminocarbonyl chloride
n,n-dimethyl carbamoyl chloride
dimethylcarbamylchlorid
dirnethylcarbamoyl chloride
n,n-dimethylchloroformamide
n,n-dimethylcarbamoylchloride
W-104263
CHEMBL1527556
mfcd00000635
F0001-2079
dimethylcarbamoyl chloride, purum, >=98.0% (at)
n,n-dimethylaminoformyl chloride
22055-85-2
Q2563907
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
halideAny heteroatomic molecular entity that is a chemical compound of halogen with other chemical elements.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency33.77250.000714.592883.7951AID1259369; AID1259392
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency15.84890.001318.074339.8107AID926; AID938
estrogen nuclear receptor alphaHomo sapiens (human)Potency54.94100.000229.305416,493.5996AID743075
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency61.13060.001723.839378.1014AID743083
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's1 (6.67)18.2507
2000's2 (13.33)29.6817
2010's1 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.29 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]